Connacht Asset Management LP Intra Cellular Therapies, Inc. Transaction History

Connacht Asset Management LP

  • $16.3 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$54.67 - $66.44 $28,100 - $34,150
-514 Reduced 6.61%
7,260 $459,000
Q1 2023

May 15, 2023
BUY
$43.8 - $56.99 $10,161 - $13,221
232 Added 3.08%
7,774 $420,000
Q4 2022

Feb 14, 2023
SELL
$44.07 - $54.45 $148,251 - $183,169
-3,364 Reduced 30.85%
7,542 $399,000
Q3 2022

Nov 14, 2022
BUY
$42.7 - $59.99 $465,686 - $654,250
10,906 New
10,906 $507,000

Others Institutions Holding ITCI

# of Institutions
381
Shares Held
84M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Connacht Asset Management LP Portfolio

Follow Connacht Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Connacht Asset Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email